46,110 Shares in Keros Therapeutics, Inc. (NASDAQ:KROS) Acquired by BNP Paribas Financial Markets
BNP Paribas Financial Markets bought a new position in Keros Therapeutics, Inc. (NASDAQ:KROS – Free Report) during the 4th quarter, according to its most recent filing with the SEC. The institutional investor bought 46,110 shares of the company’s stock, valued at approximately $730,000. Several other large investors have also recently bought and sold shares of […]
BNP Paribas Financial Markets bought a new position in Keros Therapeutics, Inc. (NASDAQ:KROS – Free Report) during the 4th quarter, according to its most recent filing with the SEC. The institutional investor bought 46,110 shares of the company’s stock, valued at approximately $730,000. Several other large investors have also recently bought and sold shares of […]
